Dr. David A. Kareken's lab focuses on understanding how inherited risks for alcohol use disorders (AUD) impact brain function, specifically looking at how brain connectivity changes during different mental states. The research aims to identify if these changes in brain networks contribute to difficulties in controlling behavior, especially in relation to alcohol consumption. By exploring these connections, the lab hopes to develop biomarkers that can help in the prevention and treatment of AUD.

Dr. Jeffrey Dage's lab focuses on finding new biomarkers for Alzheimer's disease (AD) and related conditions like progressive supranuclear palsy (PSP). By studying different forms of the tau protein in the blood, the lab aims to improve early diagnosis and understanding of these diseases. Their work involves advanced techniques to analyze blood samples from clinical trials, contributing to better detection of tau-related disorders.